Vanguard Personalized Indexing Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
53,103
+11,609
| +28% | +$320K | 0.02% | 689 |
|
|
2025
Q1 | $1.18M | Buy |
41,494
+10,547
| +34% | +$299K | 0.02% | 704 |
|
|
2024
Q4 | $1.29M | Buy |
30,947
+7,398
| +31% | +$308K | 0.02% | 660 |
|
|
2024
Q3 | $1.57M | Sell |
23,549
-6,955
| -23% | -$465K | 0.03% | 558 |
|
|
2024
Q2 | $3.62M | Buy |
30,504
+6,339
| +26% | +$753K | 0.07% | 248 |
|
|
2024
Q1 | $2.58M | Buy |
24,165
+8,023
| +50% | +$855K | 0.06% | 319 |
|
|
2023
Q4 | $1.61M | Buy |
16,142
+1,820
| +13% | +$181K | 0.04% | 428 |
|
|
2023
Q3 | $1.48M | Sell |
14,322
-1,575
| -10% | -$163K | 0.04% | 398 |
|
|
2023
Q2 | $1.93M | Sell |
15,897
-780
| -5% | -$94.8K | 0.06% | 323 |
|
|
2023
Q1 | $2.56M | Sell |
16,677
-1,424
| -8% | -$219K | 0.09% | 226 |
|
|
2022
Q4 | $3.25M | Buy |
18,101
+1,683
| +10% | +$302K | 0.13% | 146 |
|
|
2022
Q3 | $1.94M | Sell |
16,418
-1,028
| -6% | -$122K | 0.09% | 236 |
|
|
2022
Q2 | $2.49M | Buy |
17,446
+3,369
| +24% | +$481K | 0.12% | 168 |
|
|
2022
Q1 | $2.43M | Buy |
14,077
+3,714
| +36% | +$640K | 0.12% | 159 |
|
|
2021
Q4 | $2.63M | Buy |
10,363
+2,037
| +24% | +$517K | 0.16% | 111 |
|
|
2021
Q3 | $3.2M | Buy |
8,326
+810
| +11% | +$312K | 0.29% | 57 |
|
|
2021
Q2 | $1.77M | Buy |
7,516
+2,846
| +61% | +$669K | 0.18% | 112 |
|
|
2021
Q1 | $612K | Buy |
4,670
+1,364
| +41% | +$179K | 0.09% | 260 |
|
|
2020
Q4 | $345K | Buy |
+3,306
| New | +$345K | 0.08% | 316 |
|